Effects of some antiepileptic drugs in pentetrazol-induced convulsions in mice lesioned with kainic acid.
Mice were injected with intracerebroventricular (i.c.v.) kainic acid (KA; 0.1 micrograms per animal) and the pentetrazol test was carried out on the fifth day after the administration of the amino acid. The following antiepileptic drugs were tested for anticonvulsant activity in mice lesioned with KA: diazepam (0.4 mg/kg), phenobarbital (12.5 and 25 mg/kg), trimethadione (200 and 400 mg/kg), depakine (200 and 400 mg/kg), carbamazepine (10 and 20 mg/kg), lefadol (bromophenylsuccinimide; 20 mg/kg), and acetazolamide (320 mg/kg). All drugs were given intraperitoneally, except for carbamazepine, which was also given orally in doses of 100 and 200 mg/kg. Pentetrazol was administered subcutaneously in a dose of 110 mg/kg, and the animals were subsequently observed for the occurrence of clonic and tonic convulsions within 30 min. The protective effects of diazepam and phenobarbital were significantly reduced in the KA-lesioned animals, while the actions of the remaining anticonvulsants were unaltered. Moreover, a substantial loss of pyramidal cells in the CA 3 field of the hippocampus was noted after i.c.v. injection of KA. It may therefore be concluded that the mechanism of the action of diazepam and phenobarbital are partially dependent on the intact functions of the hippocampal formation.
D000086:Acetazolamide / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006624:Hippocampus / Q000187:drug effects; D007276:Injections, Intraventricular; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole; D010634:Phenobarbital / Q000627:therapeutic use; D011759:Pyrrolidines / Q000494:pharmacology*; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy*; D013388:Succinimides / Q000627:therapeutic use; D014293:Trimethadione / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D011759:Pyrrolidines; D013388:Succinimides; C002318:3-bromophenylsuccinimide; D002220:Carbamazepine; D014635:Valproic Acid; D000086:Acetazolamide; D003975:Diazepam; D014293:Trimethadione; D007608:Kainic Acid; D010433:Pentylenetetrazole; D010634:Phenobarbital